Vanguard Group Inc Axsome Therapeutics, Inc. Transaction History

Vanguard Group Inc

$6.44 Trillion
Q3 2025

A detailed history of Vanguard Group Inc transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 4,180,646 shares of AXSM stock, worth $584 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

4,180,646

Previous 3,945,020 5.97%

Holding current value

$584 Million

Previous $412 Million 23.29%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	BUY	$100.39 - $129.29 $23.7 Million - $30.5 Million	235,626 Added 5.97%	4,180,646 $508 Million
Q2 2025 Aug 11, 2025	BUY	$95.65 - $116.49 $6.51 Million - $7.93 Million	68,078 Added 1.76%	3,945,020 $412 Million
Q1 2025 May 09, 2025	SELL	$80.05 - $137.75 $2.04 Million - $3.52 Million	-25,537 Reduced 0.65%	3,876,942 $452 Million
Q4 2024 Feb 11, 2025	SELL	$83.08 - $100.49 $7.72 Million - $9.33 Million	-92,866 Reduced 2.32%	3,902,479 $330 Million
Q3 2024 Nov 13, 2024	BUY	$78.93 - $95.84 $20 Million - $24.3 Million	253,343 Added 6.77%	3,995,345 $359 Million

Q2 2024 Aug 13, 2024	BUY	$65.72 - $80.5 $113,301 - $138,782	1,724 Added 0.05%	3,742,002 $301 Million
Q1 2024 May 10, 2024	BUY	$69.39 - $97.64 $3.02 Million - $4.25 Million	43,512 Added 1.18%	3,740,278 $298 Million
Q4 2023 Feb 14, 2024	SELL	$57.42 - $83.61 $1.86 Million - $2.71 Million	-32,360 Reduced 0.87%	3,696,766 $294 Million
Q3 2023 Nov 14, 2023	SELL	$69.25 - $82.21 $943,669 - $1.12 Million	-13,627 Reduced 0.36%	3,729,126 $261 Million
Q2 2023 Aug 14, 2023	BUY	$58.41 - $90.35 $15 Million - $23.2 Million	257,003 Added 7.37%	3,742,753 $269 Million
Q1 2023 May 15, 2023	BUY	$58.39 - $75.0 $3.98 Million - $5.11 Million	68,122 Added 1.99%	3,485,750 $215 Million
Q4 2022 Feb 10, 2023	BUY	$39.94 - $79.72 $12.2 Million - $24.4 Million	306,128 Added 9.84%	3,417,628 $264 Million
Q3 2022 Nov 14, 2022	BUY	$36.06 - $69.85 $11.2 Million - $21.6 Million	309,362 Added 11.04%	3,111,500 $139 Million
Q2 2022 Aug 12, 2022	BUY	$21.74 - $46.75 $2.23 Million - $4.8 Million	102,648 Added 3.8%	2,802,138 $107 Million
Q1 2022 May 13, 2022	BUY	$23.7 - $41.39 $328,671 - $573,996	13,868 Added 0.52%	2,699,490 $112 Million
Q4 2021 Feb 14, 2022	BUY	$30.7 - $43.36 $882,225 - $1.25 Million	28,737 Added 1.08%	2,685,622 $101 Million
Q3 2021 Nov 12, 2021	BUY	$19.91 - $68.26 $850,953 - $2.92 Million	42,740 Added 1.63%	2,656,885 $87.6 Million
Q2 2021 Aug 13, 2021	BUY	$50.63 - $73.5 $132 Million - $192 Million	2,614,145 New	2,614,145 $176 Million

Others Institutions Holding AXSM

# of Institutions

414

Shares Held

36.8M

Call Options Held

752K

Put Options Held

567K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $5.99B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Axsome Therapeutics, Inc. Transaction History